a diagnosis of HIV infection (67 CD4 cells/mL) and Pneumocystis jirovecii pneumonia. He was not an identified contact of patient A, although his job entailed accompanying prisoners from remand centers to justice courts. Antiretroviral treatment (ART) given 1 month after HIV diagnosis resulted in fever 7 days later. A repeat chest radiograph showed increased opacities in the left upper zone. Sputum smear was 4+ for AFB, and MTC with rpoB gene mutation was detected (Xpert MTB/RIF; Cepheid, Sunnyvale CA, USA). Second-line anti-TB drugs were administered. MTC was grown in sputum and blood in 14 and 32 days, respectively; phenotypic DST 8 weeks later showed a susceptibility profile that was identical (except for ethambutol susceptibility) to that of patient A.
Patient C was a 43-year-old Singapore-born man arrested 1 month after receiving an HIV diagnosis and beginning ART. He withheld his HIV status from prison authorities. He shared a cell with patient A for ≈48 hours at the remand center before the chest radiograph for patient A was taken. Patient C was released after 2 days and screened as a contact 2 months later; CD4 count was <20 cells/mL despite ART. Physical examination showed peripheral lymphadenopathy. T-SPOT. TB test (Oxford Immunotec Ltd., Abingdon, UK) result was negative, chest radiographs were unremarkable, and 2 sputum smears were negative for AFB (corresponding specimens for TB culture were negative). These findings were communicated to the patient's primary physician. He was hospitalized 3 months later with fever and cough for 5 days but discharged himself, against medical advice, after 2 days. After 11 days, he was readmitted in septic shock to another hospital, at which time his sputum smear was positive for AFB and chest radiograph showed an increased right paratracheal stripe with right lower zone opacities. A bronchoesophageal fistula was also diagnosed, for which he declined intervention. Isoniazid, ethambutol, pyrazinamide, and rifabutin (his second-line ART regimen was incompatible with rifampin) were prescribed, and he discharged himself, against medical advice. After 5 days, he was readmitted with worsening cough; second-line anti-TB medications were instituted when his sputum specimen results were reported 8 weeks later as being phenotypically resistant to rifampin, isoniazid, and streptomycin. DST results for ethambutol were discrepant for isolates cultured from 2 sputum specimens and tested in 2 laboratories.
DNA genotyping by spoligotyping (Ocimum Biosolutions, Hyderabad, India) (4) showed that the isolates from all 3 patients belonged to type 467 H3, according to the SITVIT2 database (www.pasteurguadeloupe.fr:8081/SITVITDemo/). Mycobacterial interspersed repetitive units-variable number tandem repeat genotyping with a 24-loci panel (Genoscreen, Lille, France) (5) similarly showed identical profiles (Figure) . No other isolates in our database had matching profiles.
The cases reported here echo previous institutional outbreaks of MDR TB in industrialized countries (6) (7) (8) . They are a reminder of the potentially devastating consequences when HIV and MDR TB intersect and the need for infection control measures where vulnerable and/or high-risk groups congregate. For patients A and B, rapid genotypic DST expedited the MDR TB diagnosis and institution of appropriate treatment and isolation measures and curtailed further spread. The unmasking immune reconstitution inflammatory syndrome that developed in patient B exemplifies the need for TB screening before starting ART in patients from countries with mediumto-high TB prevalence. For patient C, the several-week delay in instituting second-line TB medications could have been avoided had hospital medical teams been aware of his recent MDR TB exposure.
A recent update documented the highest rates of global MDR TB in 2009 and 2010 (9) . Our experience reported here underscores the need to be constantly mindful of this infectious disease threat in our increasingly borderless world, even in countries where incidence of MDR TB is low. 
Human Infection with Marten Tapeworm
To the Editor: Cysticercosis-like human infections with the tapeworm Taenia crassiceps, which infects foxes as terminal hosts, have been reported (1,2) . We report a case of a cysticercosis-like eye infection caused by the tapeworm T. martis (marten tapeworm) in a woman.
The patient was a 43-year-old German woman who sought care during July 2010, after 4 days of perceiving flashing lights in her visual field and a paracentral scotoma in her left eye. Visual acuity in both eyes was 20/20. Examination of the left fundus revealed a mobile subretinal tumor at the temporal upper retinal branch vessel with adjacent intraretinal and subhyaloid bleeding ( Figure, The patient reported no other symptoms at that time. Laboratory evaluation found no eosinophilia or elevation of total IgE. Serologic testing results were negative for antibodies against the following parasites: Taenia solium, Echinococcus multilocularis, E. granulosus, Dirofilaria immitis, Strongyloides spp., and Toxocara canis. Fecal testing results were negative for worm eggs. Images from ultrasonography of the liver and magnetic resonance imaging of the head were unremarkable. The patient's travel history included-in addition to southern European countries-trips to Nepal and Thailand 15 years previously.
At the time of examination, the patient lived in a small village near Freiburg (im Breisgau) in southwestern Germany. She grew vegetables in the family garden, which was next to a forest. Her 3 children and husband did not report any health problems. For the past 6 years, the family had owned All material published in Emerging Infectious Diseases is in the public domain and may be used and reprinted without special permission; proper citation, however, is required.
